NexgenRx Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CAD 12.78 million compared to CAD 11.84 million a year ago. Net loss was CAD 0.022401 million compared to net income of CAD 4.02 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 CAD | -4.35% | 0.00% | 0.00% |
04-05 | NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 11.4M | |
-2.64% | 117B | |
+13.11% | 68.56B | |
+17.80% | 62.47B | |
+11.14% | 43.26B | |
+13.72% | 42.9B | |
+21.18% | 35.33B | |
+4.62% | 25.16B | |
-1.68% | 22.94B | |
+6.67% | 19.67B |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022